Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mRNA
Biotech
Moderna exits Metagenomi gene editing deal worth $3B biobucks
Earlier this year, Metagenomi had the spotlight with a $93.7 million IPO. Now, Moderna is exiting a partnership worth up to $3 billion in biobucks.
Gabrielle Masson
May 1, 2024 4:00pm
BMS pays $65M to expand Repertoire of autoimmune assets
Apr 29, 2024 6:15am
AACR: Cancer vaccines get a reintroduction
Apr 10, 2024 4:30am
AACR: BioNTech cancer vax spurs immune response 3 years in
Apr 7, 2024 2:00pm
CureVac, chasing Moderna mRNA flu shot, hits similar problems
Apr 4, 2024 9:30am
Peter Marks says FDA ready to review novel cancer vaccines
Apr 3, 2024 2:39pm